<DOC>
	<DOCNO>NCT01765907</DOCNO>
	<brief_summary>Antalgic treatment painful bone metastases US-guided High Intensity Focused Ultrasound ( HIFU ) .</brief_summary>
	<brief_title>Antalgic Treatment Painful Bone Metastases US-guided High Intensity Focused Ultrasound ( HIFU )</brief_title>
	<detailed_description>Inclusion Criteria - 18 year age old . - Histologically proven malignancy primary tumor . Histologic diagnosis may establish needle biopsy , cytology , surgical biopsy resection . If nature lesion previously biopsy , lesion treat require documentation . - Metastatic disease document either image technique ( plain radiograph , radionuclide bone scan , compute tomography scan magnetic resonance imaging ) histology . Other image technique may acceptable approval principal investigator . - ≤ 3 treatable painful bone metastasis . - `` Worst Pain Score '' &gt; 3 scale 10 24-hour period ( scored Brief Pain Inventory [ BPI ] question # 3 : 0 = pain ; 10 = worst possible pain ) despite level II analgesic medication . - Prothrombin time ( PT ) &gt; 50 % , Thrombocytes &gt; 50x109/L . - Estimated life expectancy 3 month great , estimate responsible clinician . - Targeted tumor clearly visible B-mode ultrasonography , accessible US-HIFU treatment , base imaging data . - Agreement anaesthetist IV conscious sedation - Signed study-specific inform consent prior inclusion . - Negative pregnancy test inclusion woman childbearing efficient method contraception . - Patient social security coverage . Biphosphonate , chemotherapy hormone therapy intake remain stable ( possible ) throughout follow-up duration . Exclusion criterion subject selection - Pregnant lactating woman . - Radiation therapy target site within 30 day prior enrollment . - Targeted tumor mass le 10 mm spinal cord , nerve bundle , bladder , bowel , hollow viscera , - Targeted tumor locate skull ( include facial bone ) , vertebral body sternum . - Site need surgical stabilization - Uncontrolled bleeding disorder . - Hematologic primary malignancy . - patient participate trial use drug device</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Bone Neoplasms</mesh_term>
	<mesh_term>Bone Marrow Diseases</mesh_term>
	<criteria>• 18 year age old . Histologically proven malignancy primary tumor . Histologic diagnosis may establish needle biopsy , cytology , surgical biopsy resection . If nature lesion previously biopsy , lesion treat require documentation . Metastatic disease document either image technique ( plain radiograph , radionuclide bone scan , compute tomography scan magnetic resonance imaging ) histology . Other image technique may acceptable approval principal investigator . ≤ 3 treatable painful bone metastasis . `` Worst Pain Score '' &gt; 3 scale 10 24hour period ( scored Brief Pain Inventory [ BPI ] question # 3 : 0 = pain ; 10 = worst possible pain ) despite level II analgesic medication . Prothrombin time ( PT ) &gt; 50 % , Thrombocytes &gt; 50x109/L . Estimated life expectancy 3 month great , estimate responsible clinician . Targeted tumor clearly visible Bmode ultrasonography , accessible USHIFU treatment , base imaging data . Agreement anaesthetist IV conscious sedation Signed studyspecific inform consent prior inclusion . Negative pregnancy test inclusion woman childbearing efficient method contraception . Patient social security coverage . • Pregnant lactate woman . Radiation therapy target site within 30 day prior enrollment . Targeted tumor mass le 10 mm spinal cord , nerve bundle , bladder , bowel , hollow viscera , Targeted tumor locate skull ( include facial bone ) , vertebral body sternum . Site need surgical stabilization Uncontrolled bleeding disorder . Hematologic primary malignancy . patient participate trial use drug device</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>